Mahatme Sandesh bought VOR

July 9, 2025 · Form 4 insider transaction

Mahatme Sandesh bought 13,882,750 shares of Vor Biopharma Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
13,882,750
Price
$0.00
Total value
N/A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJuly 9, 2025
Filing dateJuly 10, 2025
Shares owned after13,882,750
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents the number of shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. 1/4th of the RSUs vest on July 1, 2026, with the remainder vesting in equal quarterly installments over 3 years, in each case subject to the Reporting Person's continued service as of each such date.

View the original Form 4 on SEC EDGAR